Haimovici's Vascular Surgery 2012
DOI: 10.1002/9781118481370.ch10
|View full text |Cite
|
Sign up to set email alerts
|

Neointimal Hyperplasia: Basic Considerations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
4

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 142 publications
0
6
0
Order By: Relevance
“…A next extension of this part of the model might consider additional types of cells contributing to NIH (e.g., fibroblasts, macrophages) (Model and Dardik, 2012). …”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…A next extension of this part of the model might consider additional types of cells contributing to NIH (e.g., fibroblasts, macrophages) (Model and Dardik, 2012). …”
Section: Discussionmentioning
confidence: 99%
“…Results from the multi-scale approach using the biochemical model proposed in this paper are very encouraging even if only one type of cells was considered, i.e., smooth muscle cells. A next extension of this part of the model might consider additional types of cells contributing to NIH (e.g., fibroblasts, macrophages) (Model and Dardik, 2012 ).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Vascular restenosis is a common complication of percutaneous transluminal coronary angioplasty (PTCA) and stent implantation, which severely compromises the efficacy of treatment. Despite improvements in technology, the incidence of restenosis remains high due to neointimal hyperplasia, which results from mechanical dilating injuries and may be augmented by the presence of the stent (1). Under these circumstances, the supplementation of pharmacological treatments limiting neointimal ingrowth may improve the therapeutic outcomes.…”
Section: Introductionmentioning
confidence: 99%